Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579410 · ClinicalTrials.gov registry record
Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 85
- Enrollment target
NCT00579410: Completed study, sponsored by VA Office of Research and Development.
NCT00579410 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579410 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
Study Summary
The purpose of this research is to study the level of acid exposure above the gastroesophageal junction and the distal esophagus in patients with reflux symptoms using a capsule type acid measurement system. Patients with reflux symptoms are likely to have more acid reflux just above the junction of the stomach and the esophagus that may help to improve the diagnosis of gastroesophageal reflux disease (GERD). This may help better treat the reflux symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2004-05 |
| Est. Completion | 2009-10 |
What the finished NCT00579410 record still lists
NCT00579410 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00579410 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579410 about?
NCT00579410 is a clinical study titled "Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule". The purpose of this research is to study the level of acid exposure above the gastroesophageal junction and the distal esophagus in patients with reflux symptoms using a capsule type acid measurement system. Patients with reflux symptoms are likely to have more acid reflux just above the junction of...
What is the current status of trial NCT00579410?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2004-05. Estimated completion is 2009-10.
Who is sponsoring clinical trial NCT00579410?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia